Last Updated:
Sunday, January 23, 2022
5:18 PM
USA
Mateon Therapeutics
Mateon is a biopharmaceutical company, develops anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases.
Stock Quote
Mateon is a biopharmaceutical company, develops anti-vascular therapeutics for patients with cancer and sight-threatening eye diseases.
Newsroom
April 27, 2020
Mateon Therapeutics files IND to evaluate OT-101 in COVID-19 ...
April 27, 2020
Mateon Therapeutics files IND to evaluate OT-101 in COVID-19 ...
April 8, 2020
Mateon Expands its COVID-19 Therapeutic Program to include ...
March 3, 2020
Mateon launches antiviral programme focussed on Covid-19
Stock Quote
Vaccine
Treatment
Testing
Stats
Infographics
Menu
Vaccine
Treatment
Testing
Stats
Infographics
